赣能股份：12月9日召开董事会会议

Group 1 - The core point of the article is that Ganneng Co., Ltd. (SZ 000899) held a temporary board meeting on December 9, 2025, to discuss the proposal for changing company directors [1] - For the first half of 2025, Ganneng's revenue composition was 99.75% from electricity and 0.25% from other sources [1] - As of the report date, Ganneng's market capitalization was 9.6 billion yuan [1] Group 2 - The article also highlights a significant issue in the pharmaceutical industry regarding the abuse of pregabalin, marking the first reported case of addiction in China [1] - It mentions that online platforms have exposed loopholes allowing the purchase of medications without medical records, raising concerns about regulation [1] - The classification of pregabalin as a controlled substance is still under scientific consideration [1]